1-5 of 5
Timothy J. George, PharmD
Close
Sort by
Journal Articles

A Retrospective Study of Decitabine for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia: Lack of Response Observed In a Heavily Pretreated Population

Timothy J George, PharmD, BCOP, Joseph E Woolery, PharmD, Gene A. Wetzstein, PharmD, BCOP, Viet Q. Ho, PharmD, BCOP, Jeffrey E. Lancet, MD, Alan F. List, Rami S. Komrokji, MD
Journal: Blood
Blood (2010) 116 (21): 2186.
https://doi.org/10.1182/blood.V116.21.2186.2186
Published: 2010
Journal Articles

Salvage Chemotherapy Regimens for Acute Myeloid Leukemia: Is One Better?.

Samantha L Price, PharmD, Timothy J. George, PharmD, Gene A Wetzstein, PharmD, Jeffrey E Lancet, MD, Alan F. List, MD, Viet Q. Ho, PharmD, Hugo F. Fernandez, MD, Javier Pinilla-Ibarz, MD, PhD, Mohamed A Kharfan-Dabaja, MD, Rami S. Komrokji, MD
Journal: Blood
Blood (2009) 114 (22): 1022.
https://doi.org/10.1182/blood.V114.22.1022.1022
Published: 2009
Journal Articles

Comparable Efficacy and Safety with Voriconazole or Posaconazole as Primary Antifungal Prophylaxis in Acute Myeloid Leukemia (AML) Patients Receiving Induction Chemotherapy.

Gene A Wetzstein, PharmD, BCOP, Timothy J. George, PharmD, BCOP, Mahsa Sharifi, PharmD, Van D Hoang, PharmD, BCOP, Viet Q Ho, PharmD, BCOP, Rod E Quilitz, PharmD, BCOP, Dana A Spears, PharmD, BCOP, Rami S. Komrokji, MD, Alan F List, MD, Jeffrey E Lancet, MD, John N Greene, MD
Journal: Blood
Blood (2009) 114 (22): 2059.
https://doi.org/10.1182/blood.V114.22.2059.2059
Published: 2009
Journal Articles

Albumin Is a Prognostic Factor for Response and Overall Survival in Relapsed or Refractory Acute Myeloid Leukemia (AML).

Rami S. Komrokji, MD, Mohamed A Kharfan-Dabaja, MD, Samantha L Price, PharmD, Gene A Wetzstein, PharmD, Alan F List, MD, Hugo F. Fernandez, MD, Timothy J. George, PharmD, Javier Pinilla-Ibarz, MD, PhD, Viet Q. Ho, PharmD, Jeffrey E Lancet, MD
Journal: Blood
Blood (2009) 114 (22): 4685.
https://doi.org/10.1182/blood.V114.22.4685.4685
Published: 2009
Journal Articles

Safety, Feasibility, and Cost-Effectiveness with Outpatient Administration of High-Dose Cytarabine Consolidation in Acute Myeloid Leukemia

Gene A. Wetzstein, PharmD, BCOP, Jeffrey E. Lancet, MD, Jennifer E. Kallner, PharmD, Jeffrey M. Sivik, PharmD, BCOP, Viet Q. Ho, PharmD, BCOP, Timothy J. George, PharmD, BCOP, Sheetal Desai, PharmD, BCOP, Shanel Fisher, PharmD, Michael D. Newton, PharmD, BCOP, Alan F. List, MD
Journal: Blood
Blood (2008) 112 (11): 2405.
https://doi.org/10.1182/blood.V112.11.2405.2405
Published: 2008